A retrospective study assessing percentage of patients receiving intensified regimen of ustekinumab as well as the basic characteristics of these patients in Crohn's disease
Latest Information Update: 28 Nov 2022
At a glance
- Drugs Ustekinumab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
Most Recent Events
- 28 Nov 2022 New trial record
- 11 Oct 2022 Results presented at the 30th United European Gastroenterology Week